Literature DB >> 29082976

Integrating surgical and clinical andrology is essential to improve the quality of care delivered to infertile couples.

Sandro C Esteves1, Ahmad Majzoub2, Ashok Agarwal3.   

Abstract

Entities:  

Year:  2017        PMID: 29082976      PMCID: PMC5643673          DOI: 10.21037/tau.2017.05.37

Source DB:  PubMed          Journal:  Transl Androl Urol        ISSN: 2223-4683


× No keyword cloud information.
Drs. Yovich and Keane’s commentary (1) about the recently published clinical practice guidelines for sperm DNA fragmentation (SDF) testing based on clinical scenarios (2) is an excellent piece of writing. The authors commence by acknowledging the importance of male infertility evaluation and integration of clinical and laboratory andrology in the modern workup of infertile couples. However, they pointed out that current practice values the male factor only if semen analysis is severely abnormal in contrast to the usual comprehensive female infertility evaluation. Given the success of ICSI, male infertility is indeed often neglected. This factor is aggravated by the limitations of semen analysis, to which we concurred and discussed elsewhere (3-6). To illustrate their point, Yovich and Keane discussed the often debated issue of varicocele and male infertility. Despite overwhelming evidence confirming the adverse effect of varicocele on several sperm markers and the benefit of varicocelectomy in selected men (7-12), only recently—and after more than 150 years since the first publication about varicocele—the Cochrane review confirmed that there might be a benefit to performing varicocelectomy in subfertile men (13). Regrettably, many subfertile men could have benefitted from treatment; the benefit of performing varicocele repair using microsurgery techniques has been advocated for a long time by eminent urological microsurgeons (14-16). Along these lines, Dr. Yovich himself contributed significantly to the evolution of laboratory and clinical andrology in his distinguished career in reproductive medicine for over 35 years (17). His seminal works on human sperm function in the 90’s had a tremendous impact on clinical practice and set the path for future research (18-22). Drs. Yovich and Keane go on by suggesting ways to integrate clinical andrology as an essential element in evaluation of infertile couple. A comprehensive male evaluation including sperm function testing, such as SDF, ultrasound, use of microsurgical techniques for varicocele repair, and incorporation of clinical and surgical andrology are amongst their proposals. Additionally, the authors shared their experience in Australia, where the lack of urologists dedicated to male infertility represents a significant shortcoming to improved clinical care. To overcome this fact that seems to plague many countries alike, the authors propose the integration of both reproductive endocrinology and andrology within the scope of reproductive medicine fellowship programs. Obviously, this proposition needs to be analyzed in the perspective of each country due to the existence of plain boundaries limiting the practice of gynecologists and urologists. But if successful, urologists may become an integral part of reproductive care rather than serving as mere technicians performing sperm retrievals. Lastly, Yovich and Keane stressed the importance of quality management to fertility centers willing to improve their quality of care for both male and female, an element that we also feel to be essential as discussed elsewhere (23). Yovich and Keane overall supported the use of SDF testing in all clinical scenarios presented by Agarwal et al. (2). However, they have reservations to bypassing the epididymis as this organ is necessary for sperm maturation. The authors’ preference is to search for debris-free micro-epididymal sperm aspiration (MESA) samples containing motile spermatozoa in preference to testicular sperm extraction (TESE). We, in contrast, advocate the use of testicular sperm in preference over ejaculated and testicular sperm in men with high SDF in semen undergoing ART, provided all measures to reduce DNA damage have been attained (2). The reason is that SDF rates in testicular sperm are significantly lower than both testicular sperm and epididymal sperm (24) [(reviewed by Esteves et al. (25)]. With regards to epididymal sperm, in particular, Steele et al., using the Comet assay, showed that DNA integrity was higher (83.0%±1.2%) in testicular specimens of men with obstructive azoospermia than in proximal epididymal counterparts (75.4%±2.3%; P<0.05) (26). Their results were corroborated by Suganuma et al., who used an experimental mice model to demonstrate that the passage of sperm through the epididymis was associated with a loss of sperm DNA integrity and fertilizing capacity (27). The results of these studies and others (28) indicate that SDF may be triggered during sperm transport through the epididymis as a result of excessive oxidative stress. Therefore, the use of testicular sperm for ICSI in preference over epididymal and ejaculated sperm becomes attractive as the probability of selecting spermatozoa free of DNA damage can be increased (25).
  26 in total

Review 1.  Clinical relevance of routine semen analysis and controversies surrounding the 2010 World Health Organization criteria for semen examination.

Authors:  Sandro C Esteves
Journal:  Int Braz J Urol       Date:  2014 Jul-Aug       Impact factor: 1.541

Review 2.  A translational medicine appraisal of specialized andrology testing in unexplained male infertility.

Authors:  Sandro C Esteves; Rakesh K Sharma; Jaime Gosálvez; Ashok Agarwal
Journal:  Int Urol Nephrol       Date:  2014-04-27       Impact factor: 2.370

3.  A comparison of DNA damage in testicular and proximal epididymal spermatozoa in obstructive azoospermia.

Authors:  E K Steele; N McClure; R J Maxwell; S E Lewis
Journal:  Mol Hum Reprod       Date:  1999-09       Impact factor: 4.025

4.  Decline in fertility of mouse sperm with abnormal chromatin during epididymal passage as revealed by ICSI.

Authors:  Ryota Suganuma; Ryuzo Yanagimachi; Marvin L Meistrich
Journal:  Hum Reprod       Date:  2005-07-21       Impact factor: 6.918

5.  Diagnostic accuracy of sperm DNA degradation index (DDSi) as a potential noninvasive biomarker to identify men with varicocele-associated infertility.

Authors:  Sandro C Esteves; Jaime Gosálvez; Carmen López-Fernández; Rocío Núñez-Calonge; Pedro Caballero; Ashok Agarwal; José Luis Fernández
Journal:  Int Urol Nephrol       Date:  2015-07-31       Impact factor: 2.370

Review 6.  Specialized sperm function tests in varicocele and the future of andrology laboratory.

Authors:  Ahmad Majzoub; Sandro C Esteves; Jaime Gosálvez; Ashok Agarwal
Journal:  Asian J Androl       Date:  2016 Mar-Apr       Impact factor: 3.285

Review 7.  Outcome of assisted reproductive technology in men with treated and untreated varicocele: systematic review and meta-analysis.

Authors:  Sandro C Esteves; Matheus Roque; Ashok Agarwal
Journal:  Asian J Androl       Date:  2016 Mar-Apr       Impact factor: 3.285

Review 8.  Use of testicular sperm for intracytoplasmic sperm injection in men with high sperm DNA fragmentation: a SWOT analysis.

Authors:  Sandro C Esteves; Matheus Roque; Nicolás Garrido
Journal:  Asian J Androl       Date:  2018 Jan-Feb       Impact factor: 3.285

Review 9.  The evolution and refinements of varicocele surgery.

Authors:  Joel L Marmar
Journal:  Asian J Androl       Date:  2016 Mar-Apr       Impact factor: 3.285

Review 10.  Novel insights into the pathophysiology of varicocele and its association with reactive oxygen species and sperm DNA fragmentation.

Authors:  Chak-Lam Cho; Sandro C Esteves; Ashok Agarwal
Journal:  Asian J Androl       Date:  2016 Mar-Apr       Impact factor: 3.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.